However, our results seem to support previous literature in at-risk of AD populations describing similar anterior-ventral elevated FC and posterior diminished FC in prodromal stages of AD (Brier et al., 2012) and in cognitively normal APOE ε4 carriers (Machulda et al., 2011). This evidence concerns the gene APOE and Alzheimer disease.